Chekuri, V. and Trotter, G. (2025) Case Report: A Diagnostic Odyssey Unveiling BCGosis in an Elderly Patient. Case Reports in ...

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures.

Even so, 30% of people with bladder cancer have no identifiable risk. Fortunately for you, a noninvasive cancer was found that was less than 3 cm, which is the best possible result for bladder cancer.

In a new study, published in Cancer Cell, Dr. Glickman and his colleagues showed BCG doesn't just work locally in the bladder, but reprograms and amplifies cells in the bone marrow that give rise ...

A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the ...

Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.

From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments in bladder cancer frequently have made news over the past 12 months.

A team led by researchers at Baylor College of Medicine has identified flavonoids, natural compounds found in plants, that are toxic to bladder cancer cells cultured in the lab. The researchers report ...

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the drug demonstrated benefits in those with a higher-risk form of non ...

Learn about bladder cancer diagnosis and treatments from the experts at WebMD.

Bladder cancer happens when cells inside the organ grow out of control. Fortunately, it’s rare. WebMD explains what it is and what factors put you at risk.